There seems to be no causal relationship between genetically predicted coffee consumption and risk for migraine.
AXS-07 is an oral agent that consists of meloxicam, a COX-2 preferential nonsteroidal anti-inflammatory drug, and rizatriptan, a 5-HT1B/1D agonist.
Migraine is associated with an increased risk for burning mouth syndrome.
Headache disorders remain highly prevalent worldwide.
Presenting at the 2022 AAN Annual Meeting, researchers assessed the safety and efficacy of monthly erenumab among adult patients with chronic migraine with Asian ancestry.
Researchers sought to establish whether frequent use of a combined biofeedback-virtual reality device is associated with improvements in chronic migraine, especially in patients refractory to pharmacotherapy.
Yoga therapy may reduce the frequency of headaches for people with migraine.
The PROGRESS study compared the efficacy and safety of atogepant to placebo in 778 adults with at least a 1-year history of chronic migraine.
Elyxyb is a ready-to-use oral solution formulation of celecoxib.
For most cancers, there is no association between migraine and cancer risk.